Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration
Biomolecules · 10.05.2023 · 13 (5) · 809
DOI: 10.3390/biom13050809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 10.05.2023. Verfasst von Tadahiro Takayama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Nihon University School of Dentistry, Tokyo 101-8310, Japan. Hauptthemen laut MEDLINE: Bone Regeneration, Collagen. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American College of Prosthodontists Education Foundation Research Fellowship Award, Academy of Prosthodontics Research Grant Award, a Grant-in-Aid for Scientif…, Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, Sato Fund, Nihon University School of Dentistry.
Abstract (Originalsprache)
The use of biomaterials and bioactive agents has shown promise in bone defect repair, leading to the development of strategies for bone regeneration. Various artificial membranes, especially collagen membranes (CMs) that are widely used for periodontal therapy and provide an extracellular matrix-simulating environment, play a significant role in promoting bone regeneration. In addition, numerous growth factors (GFs) have been used as clinical applications in regenerative therapy. However, it has been established that the unregulated administration of these factors may not work to their full regenerative potential and could also trigger unfavorable side effects. The utilization of these factors in clinical settings is still restricted due to the lack of effective delivery systems and biomaterial carriers. Hence, considering the efficiency of bone regeneration, both spaces maintained using CMs and GFs can synergistically create successful outcomes in bone tissue engineering. Therefore, recent studies have demonstrated a significant interest in the potential of combining CMs and GFs to effectively promote bone repair. This approach holds great promise and has become a focal point in our research. The purpose of this review is to highlight the role of CMs containing GFs in the regeneration of bone tissue, and to discuss their use in preclinical animal models of regeneration. Additionally, the review addresses potential concerns and suggests future research directions for growth factor therapy in the field of regenerative science.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Nihon University School of Dentistry, Tokyo 101-8310, Japan.
- Division of Advanced Dental Treatment, Dental Research Center, Nihon University School of Dentistry, Tokyo 101-8310, Japan.
- Department of Periodontology, Tokyo Dental College, Tokyo 101-0061, Japan.
- Oral Health Science Center, Tokyo Dental College, Tokyo 101-0061, Japan.
- Department of Prosthodontics, New York University College of Dentistry, New York, NY 10010, USA.
ORCID-Profile: Kentaro Imamura
Förderung
- American College of Prosthodontists Education Foundation Research Fellowship Award, Academy of Prosthodontics Research Grant Award, a Grant-in-Aid for Scientif…
- Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan
- Sato Fund, Nihon University School of Dentistry
Zitieren
APA
Takayama, T., Imamura, K., & Yamano, S. (2023). Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration. Biomolecules, 13(5), 809. https://doi.org/10.3390/biom13050809
Vancouver
Takayama T, Imamura K, Yamano S. Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration. Biomolecules. 2023;13(5):809. doi:10.3390/biom13050809
BibTeX
@article{Takayama2023,
author = {Takayama, Tadahiro and Imamura, Kentaro and Yamano, Seiichi},
title = {Growth Factor Delivery Using a Collagen Membrane for Bone Tissue Regeneration},
journal = {Biomolecules},
year = {2023},
volume = {13},
number = {5},
pages = {809},
doi = {10.3390/biom13050809}
}
EUVIMED